Delivery Order SPE2DB20D3101-SPE2DB24FRBM8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.97 delivery order contract is for the supply of SYNTHROID 200 MCG TABLET 1000S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award, valued at $1,679.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of Synthroid 50 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of December 5, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,958.96 firm fixed-price delivery order is for 4,567,034,802 units of Synthroid 88 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $8,102.51 and is a delivery order for Synthroid 75 MCG Tablets (1,000 count). The contract is a Firm Fixed Price arrangement with a period of performance through March 4, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a $11,495.75 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 125 mcg Synthroid tablets. This contract does not have a set-aside designation and has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC7T6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,210.24 delivery order contract is for the supply of 4565164846 SYNTHROID 112 MCG TABLET 1000S, with a period of performance through July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,153.88, is for the delivery of Synthroid 137 MCG Tablets in 90-count packages. It is a firm fixed-price delivery order contract with a completion date of February 7, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
- This federal contract award, valued at $2,078.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 88 MCG tablets in quantities of 1,000. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,325.95 firm fixed price delivery order is for the supply of Synthroid 137 mcg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,345.51, is a Firm Fixed Price Delivery Order for the supply of SYNTHROID 100 MCG TABLET 1000S. The contract has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2022. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRBM8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.68 Firm Fixed Price Delivery Order contract is for the supply of Synthroid 112 MCG Tablets in 1,000 count packages. The contract has an ultimate completion date of February 14, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 2/13/24 |